12,123 followers
RT @FrontOncology: New research: Efficacy and safety of anti-CD38 monoclonal antibodies in patients with relapsed/refractory multiple myelo…
RT @FrontOncology: New research: Efficacy and safety of anti-CD38 monoclonal antibodies in patients with relapsed/refractory multiple myelo…
New research: Efficacy and safety of anti-CD38 monoclonal antibodies in patients with relapsed/refractory multiple myeloma: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials: Objectives The… https://t.co/